Re-envisioning radiation therapy: the future is now. Learn the benefits our customers and patients who are treated on the MRIdian system receive.
Click on the image or headline below to view a news item.
Filter by Institution
H. Lee Moffitt Cancer Center - Tampa, FL - 2.32 minutes
MDs: Dr. Stephen Rosenberg
Producer: ABC Action News
June 9, 2021
Hoag - Newport Beach, CA - 4 minutes
The ViewRay MRIdian™ linear accelerator is the most advanced radiation oncology tool available. Through the generosity of community donors Dean and Gerda Koontz, Hoag was the second in California to acquire the MRIdian, and 16th in the nation. Hoag is the first and only center in Orange County to offer this advanced radiation oncology. Learn more!
UCLA Health, Jonsson Comprehensive Cancer Center - Los Angeles, CA - 1 minutes
MDs: Dr. Amar Kishan
When Dan Howe discovered a recurrence with his prostate cancer, he enrolled in a clinical trial at UCLA Health’s Jonsson Comprehensive Cancer Center for treatment using new technology. The MRIdian LINAC allows for more precise imaging and control of cancer radiation and allowed for a shorter treatment for Dan’s cancer.
February 2, 2021
GenesisCare Oxford - Oxford, U.K. - 2:46 minutes
MDs: Dr. Philip Camilleri
BBC news story sharing the experience of GenesisCare Oxford’s first NHS Compassionate Access Programme patient as he talks to BBC South Today about the advantages of being treaded with MRIdian radiotherapy, which the programme provides without cost, to NHS patients with localised pancreatic cancer.
September 15, 2020
Providence Cancer Institute - Portland, OR - 2:!4 minutes
MDs: Kristina Young, MD
KPTV Health Watch news story about groundbreaking MR-Linac cancer radiation technology at Providence Cancer Institute in Portland, Oregon, featuring Dr. Kristina Young explaining the machine’s ability to treat tumors with pinpoint accuracy.
May 26, 2020
Herbert-Herman Cancer Center | Sparrow Health System - Lansing, MI - :01 minutes
Producer: Sparrow Health System
For the first time ever, the ViewRay MRIdian allows the radiation oncologist to see a live image of the tumor while it is being treated. This allows us to more precisely treat the tumor with higher doses and spare the healthy tissue. Learn more at SparrowCancer.org.
March 4, 2020
Sparrow Health System
Dana-Farber/Brigham and Women's Cancer Center - Boston, MA - 2:20 minutes
MDs: Joseph D. Mancias, MD, PhD
Producer: Dana-Farber Cancer Institute
Dana Farber is joining two ongoing national clinical trials testing raised radiation levels for pancreatic cancer patients and is the first center in New England to offer cancer patients MRI-guided radiation therapy.
January 24, 2020
Dana-Farber Cancer Institute
McGlinn Cancer Institute at Reading Hospital | Tower Heath - West Reading, PA - 1:00 minutes
MDs: Michael Haas, MD
Producer: Tower Health
This technology can actually decrease the number of treatments that a patient will need to go through. The automatic beam gating allows you to stop the treatment if the target moves outside or if a structure we want to avoid moves into the treatment area and allows you to visualize the tumor throughout the entire treatment process.
January 21, 2020
Reading Hospital - Tower Health
GenesisCare Oxford - Oxford, U.K. - 1:18 minutes
Watch as the very first MRIdian is installed at GenesisCare – Oxford. For the first time, cancer patients in the UK now have access to world-leading MRIdian adaptive radiotherapy treatment.
December 19, 2019
Miami Cancer Institute, Baptist Health South Florida - Miami, FL - 3:31 minutes
MDs: Dr. Michael Chuong, MD
Producer: Miami Cancer Institute at Baptist Health South Florida
For people diagnosed with certain types of cancer, hope can be distressingly elusive. That’s especially true with pancreatic cancer, but a new MRI-guided radiation therapy at Miami Cancer Institute has led to extremely encouraging outcomes, according to radiation oncologist Michael Chuong, M.D.
October 31, 2019
Baptist Health SF
The NewYork-Presbyterian Hospital and Weill Cornell Medicine - New York, NY - 2:49 minutes
MDs: Himanshu Nagar, MD and Nicholas Sanfilippo, MD
Producer: Weill Cornell Genitourinary (GU) Cancer Program
February 11, 2019
©Weill Cornell Genitourinary (GU) Cancer Program
The opinions and clinical experiences presented herein are specific to the featured physicians and the featured patients and are for information purposes only. Nothing in this material is intended to provide specific medical advice or to take the place of written law or regulations.